Close Menu
October 07, 2019
Sponsored by
Thermo Fisher Scientific

Future-Proofing a Genomics Core: Considerations When Adopting New NGS Technologies


Manager, Tumor Profiling Unit, Institute for Cancer Research in London, UK 

This webinar provides an overview of the sequencing capabilities of the Tumor Profiling Unit at the Institute for Cancer Research in London, with a focus on the lab's strategy for bringing in new genomics technologies.

Improvements in next-generation sequencing technology have historically focused on speed and throughput, while the latest advances are focused on data quality and sensitivity of detection. Adopting new technologies that offer greater genomic insights will bring current genomic labs gracefully into 2020 and beyond.

In this webinar, Nik Matthews, manager of the ICR Tumor Profiling unit, shares insight into the current state of NGS technology and considerations to remain at the forefront of improvements in data quality.


Sponsored by

Bioethicists disagree with a research team's decision to allow the return of risk results for adult-onset conditions from a newborn sequencing project, according to Reuters.

Alterations to particular gene may enable the Quechua of Peru to better tolerate high-altitude life, Ars Technica reports.

Nature News reports that additional South Korean researchers have included the names of children on scientific papers when they did not contribute to the work.

In PLOS this week: statistical approach to prioritize rare variant searches, gene expression alterations in chronic obstructive pulmonary disease, and more.

Sponsored by
Sophia Genetics

This webinar will discuss how Moffitt Cancer Center has implemented a new capture-based application to accurately assess myeloid malignancies by detecting complex variants in challenging genes in a single experiment.  

Sponsored by
BC Platforms

This webinar will discuss what it takes to begin realizing precision medicine in a comprehensive clinical infrastructure, with insights from the Colorado Center for Personalized Medicine (CCPM).

Sponsored by
Congenica II

This webinar will discuss the use of next-generation sequencing and an optimized variant interpretation workflow to increase diagnostic yield in complex clinical cases.